Physician

James Michael Calmes, MD, MBA

According to 2025 Medicare claims, James Calmes, MD, MBA (NPI: 1750363057) practices rheumatology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is ARTHRITIS & OSTEOPOROSIS ASSOCIATES, LLP (NPI: 1952354300; TIN: 752948739) and primary practice location at 79424-2862. Calmes is affiliated with the Covenant ACO, Inc. (ACO ID: A2021) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Calmes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 78,199 HCPCS/CPT codes, and received $1,157,909 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 3,993 prescription claims across 566 beneficiaries totaling $2,888,706 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2019 DME data shows 12 claims. Open Payments data shows 70 records totaling $1,016. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $628,321 to $1,157,909. Similarly, Part D prescription costs have risen steadily, from $1,427,918 to $2,888,706. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.